. 2009 Jul 8;4(7):e6184. doi: 10.1371/journal.pone.0006184

Table 3. T cells subsets (CD4⁺/CD8⁺) and T-cell activation markers (HLA-DR⁺, CD69⁺, CD25⁺, CD45RA⁺, CD45RA⁻, CD62L⁻) in peripheral blood mononuclear cells for surveys 1 and 2.

Blood T cells
Surface antigen			controls	patients
			n = 27	n = 33
CD4/CD8	(1)		1.1±0.8	1.3±0.6
			n = 13	n = 17
CD4⁺	(2)	HLA-DR⁺	23.0±4.2	26.9±5.0
CD8⁺		HLA-DR⁺	45.5±14.8	45.9±12.6
CD8⁺		CD69⁺	1.2±0.5	1.0±0.4
			n = 14	n = 16
CD4⁺	(3)	CD25⁺	3.0±1.0^*	0.3±0.2^*
CD8⁺		CD25⁺	0.4±0.5	0.2±0.1
			n = 13	n = 17
CD4⁺	(2)	CD45RA⁺	12.9±6.9	10.3±5.6
CD4⁺CD62L⁺		CD45RA⁺	19.9±9.0^*	30.1±12.8^*
CD8⁺		CD45RA⁺	48.3±21.1	41.9±15.6
CD8⁺CD62L⁺		CD45RA⁺	12.2±11.6^*	23.3±12.3^*
CD4⁺CD62L⁺		CD45RA⁻	24.7±12.2^*	42.8±15.7^*
CD8⁺CD62L⁺		CD45RA⁻	15.2±12.3	21.2±11.2
CD8⁺ CD62L⁻		CD45RA⁺	87.8±11.6^*	76.7±12.4^*
CD8⁺ CD62L⁻		CD45RA⁻	84.8±12.4	78.7±11.1

(1) n = 33 patients and 27 controls from both surveys.

(2) n = 16 patients and 14 controls from survey 2.

(3) n = 17 patients and 13 controls from survey 1. Data are expressed in percentages of total lymphocyte events acquired with the FACSCalibur (10⁴ on average)±standard deviation.

Significant difference between controls and patients (P<0.05).

Table 3. T cells subsets (CD4+/CD8+) and T-cell activation markers (HLA-DR+, CD69+, CD25+, CD45RA+, CD45RA−, CD62L−) in peripheral blood mononuclear cells for surveys 1 and 2.

Table 3. T cells subsets (CD4⁺/CD8⁺) and T-cell activation markers (HLA-DR⁺, CD69⁺, CD25⁺, CD45RA⁺, CD45RA⁻, CD62L⁻) in peripheral blood mononuclear cells for surveys 1 and 2.